Grown Rogue International Inc. Stock OTC Markets
Stocks
GRUS.F
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4650 USD | +4.75% |
|
+9.51% | -9.87% |
| 05-13 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 05-12 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 112M 97.57M 89.94M 84.28M 157M 10.77B 161M 1.07B 415M 5.19B 422M 413M 18.04B | P/E Ratio 2024 |
-12x | P/E Ratio 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 128M 111M 102M 95.74M 179M 12.23B 183M 1.22B 472M 5.9B 480M 469M 20.5B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | +4.75% | ||
| 1 week | +9.51% | ||
| Current month | +13.41% | ||
| 1 month | +25.74% | ||
| 3 months | +53.97% | ||
| 6 months | +59.85% | ||
| Current year | -9.87% |
| 1 week | 0.42 |  | 0.49 |
| 1 month | 0.33 | | 0.49 |
| Current year | 0.27 | | 0.52 |
| 1 year | 0.27 | | 0.52 |
| 3 years | 0.12 | | 0.9 |
| 5 years | 0.02 | | 0.9 |
| 10 years | 0 | | 0.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 15/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.75% | +9.51% | - | - | 112M | |
| +0.82% | +4.01% | -11.30% | -3.81% | 13.31B | |
| -1.10% | -2.21% | -35.37% | -56.82% | 4.92B | |
| -0.22% | +2.94% | -9.20% | -2.82% | 4.74B | |
| -1.86% | -5.35% | +8.38% | -21.79% | 3.78B | |
| -1.61% | +0.40% | +2.70% | -43.28% | 3.76B | |
| -2.69% | -4.14% | -5.21% | -10.76% | 3.59B | |
| -0.91% | +1.00% | -13.63% | -5.90% | 3.13B | |
| -1.50% | -2.43% | -13.60% | -32.08% | 2.25B | |
| -6.14% | -3.41% | -15.13% | +24.40% | 1.72B | |
| Average | -1.05% | -2.06% | -10.26% | -16.98% | 4.58B | |
| Weighted average by Cap. | -0.84% | -0.51% | -10.78% | -16.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.45M 21.61M 20.25M 37.84M 2.59B 38.62M 258M 99.81M 1.25B 101M 99.24M 4.34B | 32.43M 28.14M 25.94M 24.31M 45.41M 3.11B 46.36M 309M 120M 1.5B 122M 119M 5.2B |
| Net income | -11.3M -9.81M -9.04M -8.47M -15.83M -1.08B -16.16M -108M -41.76M -522M -42.43M -41.52M -1.81B | 1.73M 1.5M 1.38M 1.3M 2.42M 166M 2.47M 16.51M 6.39M 79.84M 6.49M 6.35M 278M |
| Net Debt | 3.7M 3.21M 2.96M 2.78M 5.19M 355M 5.3M 35.35M 13.69M 171M 13.91M 13.61M 594M | 15.3M 13.28M 12.24M 11.47M 21.43M 1.46B 21.87M 146M 56.52M 706M 57.43M 56.2M 2.46B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/06/26 | 0.4650 $ | +4.75% | 79,180 |
| 10/06/26 | 0.4439 $ | -4.25% | 37,565 |
| 09/06/26 | 0.4636 $ | -3.42% | 257,534 |
| 08/06/26 | 0.4800 $ | +10.55% | 574,711 |
| 05/06/26 | 0.4342 $ | +2.26% | 156,556 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
- GRUS.F Stock
Select your edition
All financial news and data tailored to specific country editions
